Solas BioVentures Emerging Healthcare Fund, LP
Amendment
CIK: 0001940916·Pooled Investment Fund·DELAWARE·Filed: May 21, 2024
Total Offering
Indefinite
Amount Sold
$35,150,000
Investors
26
First Sale
Oct 21, 2022
Offering Details
- Type
- Pooled Investment Fund
- Exemptions
- Rule 506(b), Section 3(c), Section 3(c)(1)
- Entity Type
- Limited Partnership
- Year Incorporated
- 2022
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| David Belitz | Related Person |
| Mark D. Hackett | Related Person |
| David C. Adair | Related Person |
| Solas BioVentures Emerging Healthcare GP, LLC | Related Person |
| Solas BioVentures Management, LLC | Related Person |
Company
Solas BioVentures Emerging Healthcare Fund, LP
412 GEORGIA AVENUE
CHATTANOOGA, TN, 37403
(423) 243-3460
SEC Filing
0002019886-24-000019
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free